Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release May 28 2025
Business
May 28 2025
4 min read

Press Release May 28 2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 28, 2025, titled "Zydus receives USFDA Fast Track Designation for Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of Amyotrophic Lateral Sclerosis (ALS)".

View Attachment